Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials
Amaia Eleonora Maennling(RWTH Aachen University), Ahmad Fawzi Hussain(Justus-Liebig-Universität Gießen)
Cited by 211
Related Papers
Development of SNAP-Tag Based Nanobodies as Secondary Antibody Mimics for Indirect Immunofluorescence Assays
|Cells|2025|5
Multiplex Immunofluorescence Reveals Therapeutic Targets EGFR, EpCAM, Tissue Factor, and TROP2 in Triple-Negative Breast Cancer
|International Journal of Molecular Sciences|2025|3